The Post Graduate Year Two (PGY2) Oncology Pharmacy Practice Residency at The University of Kansas Health System (UKHS) provides residents with the skills and knowledge to become a competent oncology/hematology pharmacy practitioner. The focus of the residency program is adult hematology and oncology, with experiences in hematopoietic stem cell transplantation and ambulatory oncology practice settings.

• Residency Program Purpose Statement
• Current Benefits
• Contact Us
• The Residency Learning Experience
• Application Information

---

Residency Program Purpose Statement

The purpose of the UKHS PGY2 Oncology Pharmacy Residency Program centers on the development of the knowledge, attitudes and skills needed to become a well-rounded oncology practitioner that is able to successfully practice in many different settings. It focuses upon development of special competence in applying pharmacotherapeutic intervention in cancer patients. This residency will provide educational and training experiences for pharmacists in the fundamentals of oncology pharmacy practice in an integrated health care system. Through various clinical, practice management and pharmaceutical practice training segments, the residency instills a philosophy of practice that embraces the concept that pharmacists must be accountable for optimum drug therapy outcomes and act as leaders in advancing care of patients.

Length of Program: 12 months starting early July
Number of Positions:3

Current Benefits 

• Annual Salary: $48,000 
• Other benefits include: PTO, paid holidays, health/dental/life/liability insurance 
• Click here for more Information
  
  

Contact Us

The University of Kansas Cancer Center
Department of Pharmacy
2330 Shawnee Mission Parkway, Suite 201N, Mailstop 5028
Westwood, KS 66205

PGY2 Oncology Residency Director
Zahra Mahmoudjafari, Pharm.D., BCOP, DPLA

Phone: 913-588-4753

Application information, deadlines and National Matching Services code

---

 

The Oncology Pharmacy Residency Learning Experience

The University of Kansas Cancer Center Overview
Our cancer center is one of only 70 NCI-designated cancer centers in the nation.

• National Cancer Institute (NCI) designated Cancer Center since 2011
• US News & World Report-Top 50 Cancer Program (2011-2019)
• Clinical Research Center focusing on early pre-clinical and phase I trials opened in 2012
• Over 300 hematopoietic stem cell transplants performed annually
• Over 40 cancer care clinical pharmacists
• FACT accredited (immune effector cell, BMT auto/allo program)
• NMDP accredited
• Certified CAR T cell therapy center for commercial products and investigational products
• Accredited by the American College of Surgeons Commission on Cancer since 1934
• The University of Kansas Cancer Center is a QOPI® Certified Practice

Practice Areas

The specialty residency in hematology/oncology is tailored to the interests and the career goals of each resident. A variety of practice settings are available. Required rotations are listed below: 

• Orientation (Varies) Inpatient Adult Hematology (1 month) 
• Inpatient Adult Hematopoietic Stem Cell Transplant (1 month) 
• Inpatient Adult Oncology (1 month) 
• Outpatient Adult Hematopoietic Stem Cell Transplant Clinic (1 month) 
• Outpatient Oncology/Hematology Clinic (1 month) 
• Pediatric Hematology and Oncology/Academia (2 months) 
• Cancer Center Pharmacy (1 month) 
• Inpatient Adult Hematology Advanced Independent Practice (1 month) 
• Clinical Research (1 month) 

Elective rotations are designed to provide training in areas of interest. Listed below are examples of some of the options available: 

• Repeat of any required rotation 
• Oncology administration 
• Hematology (2 weeks inpatient, 2 weeks outpatient hematology clinic) 
• Hematopoietic stem cell transplant (2 weeks inpatient, 2 weeks outpatient clinic)

---

Application Information 

PHORCAS 

Deadlines 

• Application deadline:January 4, 2019
• Must have a valid pharmacy license in the state of Kansas prior to residency start date or July 15 at latest.